U.S. Physical Therapy (NYSE:USPH) Lowered to Sell at Zacks Investment Research

U.S. Physical Therapy (NYSE:USPH) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Friday, Zacks.com reports.

According to Zacks, “U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh’s clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company’s growth, are structured like the de novo partnerships, with significant ownership retained by founders. “

Several other equities analysts have also recently weighed in on USPH. ValuEngine raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 target price for the company in a research note on Friday, November 8th. One analyst has rated the stock with a sell rating and three have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $127.20.

Shares of USPH stock opened at $114.27 on Friday. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of 43.12, a PEG ratio of 3.23 and a beta of 1.09. U.S. Physical Therapy has a one year low of $98.69 and a one year high of $148.48. The company’s fifty day moving average price is $132.85 and its 200-day moving average price is $126.64. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 1.88.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, November 7th. The company reported $0.71 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.71. The company had revenue of $117.30 million during the quarter, compared to analysts’ expectations of $121.28 million. U.S. Physical Therapy had a net margin of 6.36% and a return on equity of 16.57%. U.S. Physical Therapy’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period last year, the company posted $0.64 earnings per share. Equities research analysts expect that U.S. Physical Therapy will post 2.86 earnings per share for the current fiscal year.

In related news, CEO Christopher J. Reading sold 7,000 shares of the firm’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $135.13, for a total transaction of $945,910.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harry S. Chapman bought 2,400 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The shares were bought at an average cost of $117.00 per share, with a total value of $280,800.00. The disclosure for this purchase can be found here. Company insiders own 2.50% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Mason Street Advisors LLC grew its stake in shares of U.S. Physical Therapy by 1.8% in the 3rd quarter. Mason Street Advisors LLC now owns 4,337 shares of the company’s stock worth $566,000 after buying an additional 77 shares in the last quarter. M&T Bank Corp grew its stake in shares of U.S. Physical Therapy by 2.9% in the 2nd quarter. M&T Bank Corp now owns 3,153 shares of the company’s stock worth $386,000 after buying an additional 90 shares in the last quarter. Louisiana State Employees Retirement System grew its stake in shares of U.S. Physical Therapy by 2.1% in the 2nd quarter. Louisiana State Employees Retirement System now owns 4,800 shares of the company’s stock worth $616,000 after buying an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of U.S. Physical Therapy by 2.0% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 5,013 shares of the company’s stock worth $614,000 after buying an additional 100 shares in the last quarter. Finally, Conestoga Capital Advisors LLC grew its stake in shares of U.S. Physical Therapy by 4.6% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,755 shares of the company’s stock worth $338,000 after buying an additional 120 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: Different Options Trading Strategies

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.